Journals
Publish with us
Publishing partnerships
About us
Blog
Cardiovascular Therapeutics
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Cardiovascular Therapeutics
/
2019
/
Article
/
Fig 2
/
Research Article
Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
Figure 2
Kaplan-Meier curve of persistence on sacubitril-valsartan.